Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
Mallinckrodt
Cantor Fitzgerald
Moodys
US Army
Chubb
Medtronic
Argus Health
Express Scripts

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070325

« Back to Dashboard
NDA 070325 describes DIAZEPAM, which is a drug marketed by Martec Usa Llc, Upsher-smith Labs, Ferndale Labs, Actavis Elizabeth, Ivax Sub Teva Pharms, West-ward Pharms Int, Warner Chilcott, Watson Labs, Parenta Pharms, Us Army, Mylan, Dava Pharms Inc, Lannett Holdings Inc, Mayne Pharma, Vintage Pharms, Barr, Teva Pharms, Halsey, Roxane, Abraxis Pharm, Virtus Pharms, Watson Labs Inc, Marsam Pharms Llc, Pioneer Pharms, Hospira, and Duramed Pharms Barr, and is included in seventy-one NDAs. It is available from forty-seven suppliers. Additional details are available on the DIAZEPAM profile page.

The generic ingredient in DIAZEPAM is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.

Summary for NDA: 070325

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 070325

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 070325

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIAZEPAM
diazepam
TABLET;ORAL 070325 ANDA Mylan Pharmaceuticals Inc. 0378-0271 0378-0271-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0271-01)
DIAZEPAM
diazepam
TABLET;ORAL 070325 ANDA Mylan Pharmaceuticals Inc. 0378-0271 0378-0271-05 500 TABLET in 1 BOTTLE, PLASTIC (0378-0271-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Sep 4, 1985TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Sep 4, 1985TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Sep 4, 1985TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Argus Health
Cerilliant
Harvard Business School
Deloitte
Dow
Citi
US Army
Teva
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot